Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Merck's new PDE5 inhibitors useful for impotence, cardiovascular disorders

Nov. 24, 1999

Pfizer's portfolio includes new early-stage compounds for MED

Nov. 23, 1999

Anthranilic acid derivatives from Fujisawa particularly useful for erectile dysfunction

Nov. 22, 1999

Chronic oral treatment with SR-121463 improves water retention in cirrhotic rats

Nov. 16, 1999

VPA-985 as a novel treatment option for hyponatremia in cirrhosis: clinical results

Nov. 15, 1999

Preclinical data reported at ASN support utility of OP-1 in treating renal disease

Nov. 12, 1999

Novel agents for renal diseases with benzimidazole structure

Nov. 11, 1999

NeXstar research leads to identification of new target for treating renal disease

Nov. 11, 1999

P-selectin blocker SKK-60037 may help prevent progressive renal injuries

Nov. 9, 1999

Selectin ligand antagonist TBC-1269 attenuates renal ischemic reperfusion injury in rats

Nov. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...